2m 2m 2m 2m 2m 2m 2m
Electromed (ELMD)
NYSE
$35.70+$0.05 (+0.13%)
Price as of Jun 03, 2026 4:10 PM EDT- $312.3MMarket Cap
- 76.92%1-Year Change
- Medical DevicesIndustry
Electromed (ELMD)
$35.70+$0.05 (+0.13%)
Annual
Quarterly
06/30/2025 | 06/30/2024 | 06/30/2023 | 06/30/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 64.0M +16.97% | 54.7M +13.83% | 48.1M +15.38% | 41.7M +16.51% | |
Cost of Revenue | 14.0M +8.00% | 13.0M +12.49% | 11.5M +13.03% | 10.2M +20.90% | |
Gross Profit | 50.0M +19.76% | 41.7M +14.26% | 36.5M +16.15% | 31.4M +15.15% | |
Sales and Marketing Expense | 39.3M +13.99% | 34.5M +9.16% | 31.6M +16.53% | 27.1M +20.81% | |
Research and Development Expense | -996,000 +51.83% | -656,000 -28.38% | -916,000 -32.45% | -1.4M -21.25% | |
Depreciation and Amortization Expense | 133,000 +155.77% | 52,000 -17.46% | 63,000 -49.60% | 125,000 -6.02% | |
Total Operating Expenses | 40.3M +14.70% | 35.1M +8.10% | 32.5M +14.19% | 28.5M +17.82% | |
Operating Profit | 9.7M +46.79% | 6.6M +64.20% | 4.0M +34.86% | 3.0M -5.35% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 624,000 +37.14% | 455,000 +483.33% | 78,000 +212.00% | 25,000 -35.90% | |
Income before Taxes | 10.3M +46.16% | 7.0M +72.20% | 4.1M +36.34% | 3.0M -5.37% | |
Income Taxes | 2.7M +45.65% | 1.9M +105.00% | 920,000 +32.95% | 692,000 -14.04% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 7.5M +46.35% | 5.2M +62.67% | 3.2M +37.35% | 2.3M -2.41% | |
Net Income from Continuing Operations Applicable to Common | 10.3M +46.16% | 7.0M +72.20% | 4.1M +36.34% | 3.0M -5.37% | |
Basic EPS and Net Income | 0.89 +48.33% | 0.60 +62.16% | 0.37 +37.04% | 0.27 -3.57% | |
Diluted EPS and Net Income | 0.85 +46.55% | 0.58 +61.11% | 0.36 +38.46% | 0.26 -3.70% | |
Basic Weighted Average Shares | 8.5M -1.26% | 8.6M +1.16% | 8.5M -0.09% | 8.5M -1.11% | |
Diluted Weighted Average Shares | 8.9M +0.56% | 8.9M +1.88% | 8.7M -0.77% | 8.8M -1.61% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 15.3M -4.93% | 16.1M +118.12% | 7.4M -9.58% | 8.2M -31.42% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 15.3M -4.93% | 16.1M +118.12% | 7.4M -9.58% | 8.2M -31.42% | |
Total Current Assets | 45.1M +2.06% | 44.2M +16.90% | 37.8M +9.40% | 34.5M +8.94% | |
Accumulated Depreciation | 6.0M +16.13% | 5.2M +17.07% | 4.4M +11.54% | 4.0M -16.83% | |
Property and Plant and Equipment and Net | 4.7M -8.73% | 5.2M -8.94% | 5.7M +24.17% | 4.6M +26.71% | |
Total Long-Term Assets | 1.2M +1,248.28% | 87,000 -45.96% | 161,000 +34.17% | 120,000 +36.36% | |
Total Assets | 53.8M +3.00% | 52.2M +14.03% | 45.8M +10.74% | 41.4M +11.47% | |
Income Taxes Payable | 0 -100.00% | 277,000 -17.56% | 336,000 +558.82% | 51,000 -82.29% | |
Total Short-Term Debt | 0 N/A | 0 N/A | 0 N/A | 0 -100.00% | |
Total Current Liabilities | 10.5M +36.36% | 7.7M -4.67% | 8.1M +12.63% | 7.2M +54.13% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 125,000 +941.67% | 12,000 -86.05% | 86,000 +109.76% | 41,000 -24.07% | |
Total Liabilities | 10.6M +37.77% | 7.7M -5.53% | 8.1M +13.18% | 7.2M +53.23% | |
Retained Earnings | 21.2M -10.49% | 23.7M +25.94% | 18.8M +19.09% | 15.8M +5.75% | |
Total Stockholders Equity | 43.2M -3.00% | 44.5M +18.26% | 37.7M +10.22% | 34.2M +5.42% | |
Total Shares Outstanding | 8.3M -3.34% | 8.6M +0.97% | 8.6M +0.94% | 8.5M -0.68% | |
Cash Flow | |||||
Cash from Operating Activities | 11.4M +25.65% | 9.1M +589.51% | 1.3M +291.69% | -686,000 -122.29% | |
Capital Expenditures | 262,000 -8.71% | 287,000 -82.58% | 1.6M +15.65% | 1.4M +396.52% | |
Cash from Investing Activities | -306,000 -22.53% | -395,000 -76.98% | -1.7M +12.52% | -1.5M +240.40% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -11.9M -33,100.00% | 36,000 +109.47% | -380,000 -75.08% | -1.5M +25.10% | |
Financials Ratio | |||||
Gross Margin | 78.08% +2.39% | 76.26% +0.37% | 75.98% +0.66% | 75.47% -1.17% | |
Operating Margin | 15.09% +25.49% | 12.03% +44.24% | 8.34% +16.88% | 7.13% -18.76% | |
Return on Assets | 14.22% +35.31% | 10.51% +44.63% | 7.26% +23.65% | 5.87% -12.51% | |
Return on Equity | 17.18% +37.11% | 12.53% +42.14% | 8.81% +27.31% | 6.92% -8.16% | |
Revenue Growth | 16.97% +22.66% | 13.83% -10.07% | 15.38% -6.83% | 16.51% +63.17% | |
Current Ratio | 4.31 -25.15% | 5.75 +22.62% | 4.69 -2.86% | 4.83 -29.32% | |
Cash Ratio | 1.46 -30.28% | 2.09 +128.82% | 0.92 -19.72% | 1.14 -55.51% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow